Rydar Equities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.62M Buy
14,023
+781
+6% +$206K 1.87% 11
2026
Q2
$3.36M Buy
13,242
+7,222
+120% +$1.68M 1.89% 11
2026
Q1
$1.47M Buy
6,020
+2,045
+51% +$476K 1.14% 31
2025
Q4
$823K Buy
3,975
+1,460
+58% +$289K 0.64% 45
2025
Q3
$468K Sell
2,515
-3,178
-56% -$544K 0.37% 62
2025
Q2
$870K Buy
+5,693
New +$875K 0.69% 44

Other funds holding JNJ

Rydar Equities's JNJ Position: Q3 2026 in Review

Rydar Equities increased its Johnson & Johnson (JNJ) stake by 5.9% in Q3 2026, buying an estimated $206K and bringing the position to 14,023 shares worth $3.62M. The position accounts for 1.87% of the portfolio, ranked #11.

Rydar Equities first reported a position in JNJ in Q2 2025 and has held it in 6 quarters since. 1,216 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Rydar Equities held 14,023 shares of Johnson & Johnson worth $3.62M as of Q3 2026.
  • Rydar Equities bought 781 Johnson & Johnson shares in Q3 2026, an estimated $206K.
  • Johnson & Johnson made up 1.87% of Rydar Equities's portfolio in Q3 2026, its #11 holding.
  • Rydar Equities first reported a position in Johnson & Johnson in Q2 2025 and has held it in 6 quarters since.
  • 1,216 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.